Surgical margin status and its impact on prostate cancer prognosis after radical prostatectomy: a meta-analysis

World J Urol. 2018 Nov;36(11):1803-1815. doi: 10.1007/s00345-018-2333-4. Epub 2018 May 15.

Abstract

Background and purpose: Positive surgical margins (PSMs) correlate with adverse outcomes in numerous solid tumours. However, the prognostic value of PSMs in prostate cancer (PCa) patients who underwent radical prostatectomy remains unclear. Herein, we performed a meta-analysis to evaluate the association between PSMs and the prognostic value for biochemical recurrence-free survival (BRFS), cancer-specific survival (CSS), overall survival (OS), cancer-specific mortality (CSM) and overall mortality (OM) in PCa patients.

Materials and methods: According to the PRISMA statement, online databases PubMed, EMBASE and Web of Science were searched to identify relevant studies published prior to February 2018. The hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated to evaluate the relationship between PSMs and PCa.

Results: Ultimately, 32 cohort studies that met the eligibility criteria and involved 141,222 patients (51-65,633 per study) were included in this meta-analysis. The results showed that PSMs were significantly predictive of poorer BRFS (HR = 1.35, 95% CI 1.28-1.48, p < 0.001), CSS (HR = 1.49, 95% CI 1.16-1.90, p = 0.001) and OS (HR = 1.11, 95% CI 1.02-1.20, p = 0.014). In addition, PSMs were significantly associated with higher risk of CSM (HR = 1.23, 95% CI 1.16-1.30, p < 0.001) and OM (HR = 1.09, 95% CI 1.02-1.16, p = 0.009) in patients with PCa.

Conclusions: Our study suggests that the presence of a histopathologic PSM is associated with the clinical outcomes BRFS, CSS, OS, CSM and OM in patients with PCa, and PSMs could serve as a poor prognostic factor for patients with PCa.

Keywords: Meta-analysis; Positive surgical margin; Prognosis; Prostate cancer; Radical prostatectomy.

Publication types

  • Meta-Analysis

MeSH terms

  • Cause of Death
  • Disease-Free Survival
  • Humans
  • Male
  • Margins of Excision*
  • Prognosis
  • Proportional Hazards Models
  • Prostatectomy*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / surgery*
  • Survival Rate